Capricor Therapeutics Inc (NASDAQ: CAPR) is -4.49% lower on its value in year-to-date trading and has touched a low of $3.52 and a high of $23.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CAPR stock was last observed hovering at around $13.48 in the last trading session, with the day’s loss setting it -0.3%.
Currently trading at $13.18, the stock is -0.17% and -5.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.01 million and changing -2.23% at the moment leaves the stock 13.99% off its SMA200. CAPR registered 106.58% gain for a year compared to 6-month gain of 120.77%. The firm has a 50-day simple moving average (SMA 50) of $14.0 and a 200-day simple moving average (SMA200) of $11.52385.
The stock witnessed a -16.58% loss in the last 1 month and extending the period to 3 months gives it a 0.84%, and is 7.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.88% over the week and 10.44% over the month.
Capricor Therapeutics Inc (CAPR) has around 102 employees, a market worth around $599.29M and $22.27M in sales. Fwd P/E is 346.84. Profit margin for the company is -181.71%. Distance from 52-week low is 274.43% and -43.68% from its 52-week high. The company has generated returns on investments over the last 12 months (-55.84%).
The EPS is expected to grow by 34.04% this year
148.0 institutions hold shares in Capricor Therapeutics Inc (CAPR), with institutional investors hold 45.88% of the company’s shares. The shares outstanding are 45.58M, and float is at 39.94M with Short Float at 22.72%. Institutions hold 38.17% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.63 million shares valued at $7.77 million. The investor’s holdings represent 5.1145 of the CAPR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.55 million shares valued at $7.39 million to account for 4.9401 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.64 million shares representing 2.0462 and valued at over $3.06 million, while MILLENNIUM MANAGEMENT LLC holds 1.5059 of the shares totaling 0.48 million with a market value of $2.29 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Nippon Shinyaku Co Ltd, the company’s 10% Owner. SEC filings show that Nippon Shinyaku Co Ltd bought 2,798,507 shares of the company’s common stock on Sep 20 ’24 at a price of $5.36 per share for a total of $15.0 million. Following the purchase, the insider now owns 7.09 million shares.
